Opsidio LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.opsidio.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis
Phase 2
Active, not recruiting
- Conditions
- Atopic Dermatitis
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Opsidio, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06101823
- Locations
- 🇺🇸
Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, United States
🇺🇸First OC Dermatology Research, Fountain Valley, California, United States
🇺🇸Axon Clinical Research, Inglewood, California, United States
News
No news found